Abstract
In the 18th century clinical cardiology was based on pulse examination and auscultation by placing the ear directly on the patient’s chest, while diagnosis of heart diseases was done in postmortem examination. In 1749, Jean-Baptiste de Sénac, physician of King Louis XV, published his work on the heart Traité de la structure du coeur, de son action et de ses maladies. It was the result of years of anatomical and physiological study, in an attempt to illuminate heart and its functions. Sénac recognized among several heart disorders, aortic regurgitation, mitral calcification, and mitral regurgitation. His work remained a landmark in valvular pathology and cardiology until the early 19th century.
Keywords: Jean-Baptiste de Sénac, 18th century history of medicine, history of cardiology, valvular diseases.
Current Pharmaceutical Design
Title:Jean-Baptiste de Sénac’s (1693-1770) Important Work on Cardiology and Valvular Disorders
Volume: 22 Issue: 13
Author(s): Marianna Karamanou, Gregory Tsoucalas, Elias Gialafos, Dimitris A. Vrachatis, George Androutsos and Effie Poulakou-Rebelakou
Affiliation:
Keywords: Jean-Baptiste de Sénac, 18th century history of medicine, history of cardiology, valvular diseases.
Abstract: In the 18th century clinical cardiology was based on pulse examination and auscultation by placing the ear directly on the patient’s chest, while diagnosis of heart diseases was done in postmortem examination. In 1749, Jean-Baptiste de Sénac, physician of King Louis XV, published his work on the heart Traité de la structure du coeur, de son action et de ses maladies. It was the result of years of anatomical and physiological study, in an attempt to illuminate heart and its functions. Sénac recognized among several heart disorders, aortic regurgitation, mitral calcification, and mitral regurgitation. His work remained a landmark in valvular pathology and cardiology until the early 19th century.
Export Options
About this article
Cite this article as:
Karamanou Marianna, Tsoucalas Gregory, Gialafos Elias, A. Vrachatis Dimitris, Androutsos George and Poulakou-Rebelakou Effie, Jean-Baptiste de Sénac’s (1693-1770) Important Work on Cardiology and Valvular Disorders, Current Pharmaceutical Design 2016; 22 (13) . https://dx.doi.org/10.2174/1381612822666151208120832
DOI https://dx.doi.org/10.2174/1381612822666151208120832 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employ in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, prediction, to monitor of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal fluid ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Statins: The Holy Grail of Abdominal Aortic Aneurysm (AAA) Growth Attenuation? A Systematic Review of the Literature
Current Vascular Pharmacology Enzyme Inhibition in Managing Cardiovascular Diseases
Current Enzyme Inhibition Adipoparacrinology of Atherosclerosis: Evidence Updated
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Study of Prolactin Permeation Through the Pericardium and Its Bioavailability
Protein & Peptide Letters Vitamin D in Acute Kidney Injury
Inflammation & Allergy - Drug Targets (Discontinued) RNA Silencing: Recent Developments on miRNAs
Recent Patents on DNA & Gene Sequences Chemokines as Potential Therapeutic Targets in Atherosclerosis
Current Drug Targets The Role of Adipocytokines in Atherogenesis and Atheroprogression
Current Drug Targets Arthritis and Periodontitis: An Association Debated for Over Two Centuries
Current Rheumatology Reviews Long Term Cardiovascular Risk in Women
Vascular Disease Prevention (Discontinued) The Use of Carvedilol in Pediatric Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets Mitochondrial MMP Activation, Dysfunction and Arrhythmogenesis in Hyperhomocysteinemia
Current Vascular Pharmacology The Role of Chinese Herbal Medicines and Bioactive Ingredients Targeting Myocardial KCa and KATP Channels in Cardiovascular Diseases
Current Pharmaceutical Design Current Updates on Therapeutic Advances in the Management of Cardiovascular Diseases
Current Pharmaceutical Design Digitalis Purpurea: Hope for Myocardial Infarction Induced by Obesity - A Review
Current Indian Science AMPK: Potential Therapeutic Target for Alzheimer's Disease
Current Protein & Peptide Science Genetic Variability of Matrix Metalloproteinase Genes in Cardiovascular Disease
Current Topics in Medicinal Chemistry Hyperthermia: From Diagnostic and Treatments to New Discoveries
Recent Patents on Biotechnology Evaluation of Clinical Efficacy of Fasudil for the Treatment of Pulmonary Arterial Hypertension
Recent Patents on Cardiovascular Drug Discovery Application of Current Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy in Every Day Clinical Practice
Current Pharmaceutical Design